• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性标记抗体:癌症治疗中的结果与潜力

Radiolabeled antibodies: results and potential in cancer therapy.

作者信息

Order S E, Sleeper A M, Stillwagon G B, Klein J L, Leichner P K

机构信息

Department of Radiation Oncology, Johns Hopkins Hospital, Baltimore, Maryland 21205.

出版信息

Cancer Res. 1990 Feb 1;50(3 Suppl):1011s-1013s.

PMID:2404579
Abstract

Radiolabeled antibodies are analyzed from the classical approach in radiation oncology being compared to geometric isotopic implants, external radiation, and tumor-dose response and energy of the isotope used for cytotoxicity. In addition, physiological factors that limit antibody uptake, varied routes of administration, toxicity of treatment, as well as present clinical progress are reviewed.

摘要

将放射性标记抗体与几何同位素植入、外照射、肿瘤剂量反应以及用于细胞毒性的同位素能量进行比较,采用放射肿瘤学的经典方法对其进行分析。此外,还综述了限制抗体摄取的生理因素、不同的给药途径、治疗毒性以及目前的临床进展。

相似文献

1
Radiolabeled antibodies: results and potential in cancer therapy.放射性标记抗体:癌症治疗中的结果与潜力
Cancer Res. 1990 Feb 1;50(3 Suppl):1011s-1013s.
2
Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.90Y标记的B72.3腹腔给药治疗卵巢癌的I期研究:剂量及乙二胺四乙酸共同给药对药代动力学和毒性的影响
Clin Cancer Res. 1999 May;5(5):953-61.
3
Dosimetric aspects of radiolabeled antibodies for tumor therapy.用于肿瘤治疗的放射性标记抗体的剂量学方面
J Nucl Med. 1986 Sep;27(9):1490-7.
4
Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.永久性前列腺植入的同位素选择?基于放射生物学有效性和剂量学对¹⁰³Pd与¹²⁵I的评估。
Semin Urol Oncol. 2000 May;18(2):152-9.
5
Time-dose-fractionation in radioimmunotherapy: implications for selecting radionuclides.放射免疫治疗中的时间-剂量-分割:对放射性核素选择的影响
J Nucl Med. 1993 Oct;34(10):1801-10.
6
Systemic targeted radionuclide therapy: potential new areas.全身靶向放射性核素治疗:潜在的新领域。
Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S74-82. doi: 10.1016/j.ijrobp.2005.05.029.
7
[Intra-arterial regional administration of radioactive preparations in treating malignant tumors].
Vopr Onkol. 1978;24(1):99-109.
8
Outpatient administration of radiolabeled monoclonal antibodies.放射性标记单克隆抗体的门诊给药。
Clin J Oncol Nurs. 2003 Jan-Feb;7(1):106-8. doi: 10.1188/03.CJON.104-108.
9
International Clinical Trials in Radiation Oncology. Isotopic immunotherapy: radiolabelled antibody.放射肿瘤学国际临床试验。同位素免疫疗法:放射性标记抗体。
Int J Radiat Oncol Biol Phys. 1988;14 Suppl 1:S77-81.
10
Current status of radioimmunoglobulins in the treatment of human malignancy.放射免疫球蛋白在人类恶性肿瘤治疗中的现状
Oncology (Williston Park). 1989 May;3(5):115-20; discussion 122, 129-30.

引用本文的文献

1
Therapy and imaging of pancreatic carcinoma xenografts with radioiodine-labeled chimeric monoclonal antibody A10 and its Fab fragment.用放射性碘标记的嵌合单克隆抗体A10及其Fab片段对胰腺癌异种移植瘤进行治疗和成像
Jpn J Cancer Res. 1995 Dec;86(12):1216-23. doi: 10.1111/j.1349-7006.1995.tb03318.x.
2
Modulation of drug-induced cytotoxicity by a bispecific monoclonal antibody that recognizes the epidermal growth factor receptor and doxorubicin.一种识别表皮生长因子受体和阿霉素的双特异性单克隆抗体对药物诱导的细胞毒性的调节作用
Cancer Immunol Immunother. 1994 Mar;38(3):171-7. doi: 10.1007/BF01525638.
3
Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA).
铟和钇标记的与2-(对-异硫氰酸苄基)-6-甲基二乙三胺五乙酸(1B4M-DTPA)或2-(对-异硫氰酸苄基)-1,4,7,10-四氮杂环十二烷四乙酸(2B-DOTA)偶联的B3单克隆抗体的比较生物分布。
Eur J Nucl Med. 1994 Jul;21(7):640-6. doi: 10.1007/BF00285586.
4
Activation of T lymphocytes for the adoptive immunotherapy of cancer.用于癌症过继性免疫治疗的T淋巴细胞激活。
Ann Surg Oncol. 1994 Jul;1(4):296-306. doi: 10.1007/BF02303568.
5
The scientific bases of cancer management: at the interface between fundamental research and clinical practice.癌症管理的科学基础:基础研究与临床实践的交汇点。
J Cancer Res Clin Oncol. 1991;117(4):275-89. doi: 10.1007/BF01630709.
6
Monoclonal antibodies in imaging and therapy of colorectal cancer.单克隆抗体在结直肠癌成像与治疗中的应用
World J Surg. 1991 Sep-Oct;15(5):617-22. doi: 10.1007/BF01789208.
7
Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity.阿霉素(腙)-抗体偶联物需要内化和细胞内酸水解才能发挥抗肿瘤活性。
Cancer Immunol Immunother. 1991;33(6):367-74. doi: 10.1007/BF01741596.